Showing results (321-330 of 352) with videos related to
Sort By:
Pageof 36
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|April 24, 2023
The activities and mechanisms of intestinal microbiota metabolites of TCM herbal ingredients could be illustrated by a strategy integrating spectrum-effects, network pharmacology, metabolomics and molecular docking analysis: Platycodin D as an exampleYuan-Han Zhong, Jian Liang, Qian Qin, et al.American Journal of Translational Research|January 22, 2019
Reduced selenium-binding protein 1 correlates with a poor prognosis in intrahepatic cholangiocarcinoma and promotes the cell epithelial-mesenchymal transitionXin-Yu Zhang, Ping-Ting Gao, Xuan Yang, et al.Journal of the American Chemical Society|January 28, 2025
Fractional Spinon Quasiparticles in Open-Shell Triangulene Spin-1/2 ChainsZhangyu Yuan, Xin-Yu Zhang, Yashi Jiang, et al.Cancer Science|November 4, 2024
The prognostic significance of MYC/BCL2 double expression in DLBCL in the genetic classification eraYi-Fan Wu, Qun-Hui Yuan, Hao-Rui Shen, et al.International Journal of Molecular Sciences|October 3, 2018
Design, Synthesis, and Cytotoxic Analysis of Novel Hederagenin⁻Pyrazine Derivatives Based on Partial Least Squares Discriminant AnalysisKang Fang, Xiao-Hua Zhang, Yao-Tian Han, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|December 22, 2023
Detection of Helicobacter pylori Infection in Human Gastric Fluid Through Surface-Enhanced Raman Spectroscopy Coupled With Machine Learning AlgorithmsJia-Wei Tang, Fen Li, Xin Liu, et al.Blood Cancer Journal|February 11, 2026
Penpulimab combined with rituximab, high-dose methotrexate, and cytarabine (Pen-RMA) in newly diagnosed primary central nervous system lymphoma (PCNSL): a phase 2 trialHao-Rui Shen, Jia-Zhu Wu, Hua Yin, et al.BMC Medicine|July 10, 2026
R-MINE-containing regimen in relapsed and refractory diffuse large B-cell lymphoma: a single-arm, multicenter phase II studyJin-Hua Liang, Xin-Yu Zhang, Lin-Tao Bi, et al.Cancer Letters|April 14, 2024
PRMT5 activates lipid metabolic reprogramming via MYC contributing to the growth and survival of mantle cell lymphomaJin-Hua Liang, Wei-Ting Wang, Rong Wang, et al.Cancer Research and Treatment|July 31, 2025
A Novel CD58 Mutation-Related Signature Predicts Prognosis Risk in Diffuse Large B-Cell Lymphoma PatientsHui-Li Wang, Chun-Yu Shang, Wei Hua, et al.Pageof 36